The obtained results on the complex deregulation of GLCE expression and promoter methylation in prostate pathology suggest that GLCE may be a gene of interest in the study of the functional role of intratumor cell heterogeneity in prostate cancer progression and treatment. This evidence concerns the gene GLCE and prostate cancer.